CSF1R and neuroblastoma: It was earlier reported that the targeting of MDSCs by use of colony stimulating factor 1 receptor blockade synergizes with α-PD-1/α-PD-L1 checkpoint inhibition in reducing murine neuroblastoma progression in vivo [11].